Innoviva, Inc.
INVA
$20.86
$0.281.36%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 144.42M | 128.97M | 128.72M | 116.98M | 107.37M |
| Total Other Revenue | 244.10M | 241.26M | 241.13M | 241.73M | 245.38M |
| Total Revenue | 388.52M | 370.23M | 369.84M | 358.71M | 352.75M |
| Cost of Revenue | 76.18M | 60.48M | 52.94M | 47.96M | 67.13M |
| Gross Profit | 312.35M | 309.75M | 316.90M | 310.76M | 285.61M |
| SG&A Expenses | 112.64M | 111.49M | 112.82M | 115.73M | 110.72M |
| Depreciation & Amortization | 26.15M | 26.04M | 25.94M | 25.90M | 25.90M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 218.66M | 191.71M | 185.39M | 183.28M | 176.66M |
| Operating Income | 169.86M | 178.52M | 184.45M | 175.43M | 176.08M |
| Income Before Tax | 156.52M | 65.55M | -46.33M | 37.39M | 73.90M |
| Income Tax Expenses | 29.18M | 26.90M | 13.40M | 14.00M | 9.30M |
| Earnings from Continuing Operations | 127.34 | 38.65 | -59.72 | 23.39 | 64.59 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 127.34M | 38.65M | -59.72M | 23.39M | 64.59M |
| EBIT | 169.86M | 178.52M | 184.45M | 175.43M | 176.08M |
| EBITDA | 196.14M | 204.68M | 210.50M | 201.46M | 202.11M |
| EPS Basic | 1.90 | 0.61 | -0.95 | 0.37 | 1.01 |
| Normalized Basic EPS | 1.66 | 1.76 | 1.80 | 1.69 | 1.66 |
| EPS Diluted | 1.39 | 0.33 | -1.00 | 0.21 | 0.69 |
| Normalized Diluted EPS | 1.36 | 1.52 | 1.68 | 1.49 | 1.47 |
| Average Basic Shares Outstanding | 257.26M | 250.77M | 250.43M | 250.91M | 251.99M |
| Average Diluted Shares Outstanding | 316.33M | 294.31M | 272.39M | 294.21M | 295.00M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |